1-3 of 3
Mohsen El Alfy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multivariate Analysis Evaluating Potential Predictors of Cardiac T2* Where Cardiac Magnetic Resonance Imaging (CMR) Availability Is Limited

John B Porter, MD, Ali T Taher, MD PhD, Yesim Aydinok, MD, Amal El-Beshlawy, MD/Professor, Mohsen El-Alfy, MD, Ali El-Ali, MD, Subhashish Chakravarty, PhD, M Domenica Cappellini, MD
Journal: Blood
Blood (2014) 124 (21): 1366.
https://doi.org/10.1182/blood.V124.21.1366.1366
Published: 2014
Journal Articles

Interim Safety and Effectiveness Results From a 5-Year Observational Study of Deferasirox in Pediatric Patients Aged 2–<6 Years At Enrollment.

Elliott Vichinsky, MD, Amal El-Beshlawy, MD, Azzam Alzoebie, MD, Francoise Bernaudin, MD, Suzanne Koussa, MD, Thirachit Chotsampancharoen, MD, Ali El-Ali, MD, Caroline Arrowsmith, Nicolas Martin, MS, Mohsen El-Alfy, MD
Journal: Blood
Blood (2012) 120 (21): 2125.
https://doi.org/10.1182/blood.V120.21.2125.2125
Published: 2012
Journal Articles

Deferasirox (Exjade ® , ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial.

Ali Taher, Amal El-Beshlawy, Abdullah Al Jefri, Mohsen El Alfy, Kusai Al Zir, Shahina Daar, Ghazi Al-Damanhouri, Dietrich Hadler, Ulrike Krahn
Journal: Blood
Blood (2005) 106 (11): 3840.
https://doi.org/10.1182/blood.V106.11.3840.3840
Published: 2005